Medical - Diagnostics/Research Stocks
The companies in this industry provide analysis and diagnostic services by examining body fluids and producing images of the body for medical professionals and patients. Demand correlates with the number of people receiving medical treatment. The profitability of individual companies depends on efficient operations and take advantage of the ability to draw business from a wide geographical area.
Share This Page
B
Industry Rank
This industry ranks #59 out of 123 stock categories.
B
Average POWR Rating
The average market cap-weighted POWR Rating for stocks in this industry is B (Buy).
| Rk | Symbol | Name | Last | Open | High | Low | 52WK Hi | 52WK Lo | Day Chg | YTD Chg | 12M Chg | Mkt Cap | 50D MA | ± 50D | 200D MA | ± 200D | POWR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc | 317.32 | 317.23 | 318.08 | 315.17 | 321.60 | 208.34 | 0.89 (0.28%) |
42.08% | 33.93% | 127.24B | 297.09 | 6.81% | 282.40 | 12.37% |
A Strong Buy |
| 2 | A | Agilent Technologies, Inc. | 82.83 | 82.90 | 83.80 | 82.70 | 83.80 | 62.00 | 1.21 (1.48%) |
23.57% | 17.51% | 25.63B | 76.94 | 7.66% | 74.65 | 10.95% |
A Strong Buy |
| 3 | LH | Laboratory Corporation of America Holdings | 167.78 | 165.00 | 168.62 | 163.45 | 178.44 | 119.38 | -1.30 (-0.77%) |
32.78% | 20.24% | 16.29B | 167.99 | -0.13% | 164.77 | 1.82% |
A Strong Buy |
| 4 | DGX | Quest Diagnostics Incorporated | 104.95 | 105.23 | 105.75 | 104.95 | 108.30 | 78.95 | -0.28 (-0.27%) |
28.87% | 20.21% | 14.14B | 103.66 | 1.24% | 98.32 | 6.74% |
A Strong Buy |
| 5 | BIO | Bio-Rad Laboratories, Inc. | 354.37 | 357.20 | 357.99 | 339.00 | 376.43 | 220.05 | -3.24 (-0.91%) |
52.60% | 40.78% | 10.61B | 348.66 | 1.64% | 320.76 | 10.48% |
A Strong Buy |
| 6 | QGEN | Qiagen N.V. Common Shares | 41.70 | 41.33 | 41.85 | 41.32 | 43.16 | 25.04 | 0.18 (0.43%) |
21.04% | 17.94% | 9.40B | 33.76 | 23.52% | 36.93 | 12.90% |
A Strong Buy |
| 7 | ICLR | ICON plc - Ordinary Shares | 162.32 | 161.22 | 162.61 | 159.51 | 165.13 | 118.10 | 1.09 (0.68%) |
25.62% | 16.68% | 8.76B | 150.20 | 8.07% | 146.36 | 10.90% |
A Strong Buy |
| 8 | BRKR | Bruker Corporation | 50.11 | 49.66 | 50.31 | 49.44 | 52.23 | 26.10 | 0.44 (0.89%) |
68.95% | 60.47% | 7.72B | 46.70 | 7.30% | 43.61 | 14.90% |
A Strong Buy |
| 9 | CRL | Charles River Laboratories International, Inc. | 145.90 | 145.15 | 146.31 | 143.92 | 149.07 | 103.00 | 1.19 (0.82%) |
28.91% | 14.26% | 7.13B | 135.04 | 8.05% | 135.79 | 7.45% |
A Strong Buy |
| 10 | SYNH | Syneos Health, Inc. - | 56.11 | 55.40 | 56.12 | 55.05 | 56.34 | 36.26 | 0.80 (1.45%) |
42.59% | 17.73% | 5.82B | 52.58 | 6.71% | 49.58 | 13.18% |
A Strong Buy |
| 11 | QDEL | Quidel Corporation | 71.83 | 71.09 | 72.25 | 70.52 | 72.38 | 44.27 | 0.74 (1.04%) |
47.13% | 49.72% | 2.99B | 62.07 | 15.72% | 61.29 | 17.20% |
A Strong Buy |
| 12 | NEO | NeoGenomics, Inc. | 26.32 | 25.94 | 26.57 | 25.70 | 26.89 | 11.05 | 0.35 (1.35%) |
108.72% | 89.24% | 2.75B | 22.44 | 17.30% | 22.26 | 18.27% |
A Strong Buy |
| 13 | RDNT | RadNet, Inc. | 19.59 | 19.69 | 19.92 | 19.53 | 20.42 | 9.97 | -0.03 (-0.15%) |
92.63% | 56.86% | 984.83M | 16.36 | 19.72% | 14.35 | 36.47% |
A Strong Buy |
| 14 | IQV | IQVIA Holdings, Inc. | 145.81 | 146.70 | 146.98 | 145.02 | 164.13 | 104.90 | -0.59 (-0.40%) |
25.51% | 22.55% | 28.29B | 144.80 | 0.70% | 146.42 | -0.42% |
B Buy |
| 15 | PRAH | PRA Health Sciences, Inc. | 107.30 | 107.03 | 108.13 | 106.67 | 115.50 | 82.12 | 0.24 (0.22%) |
16.68% | 2.46% | 6.79B | 101.37 | 5.85% | 99.46 | 7.89% |
B Buy |
| 16 | NEOG | Neogen Corporation | 67.01 | 66.54 | 67.27 | 66.53 | 79.83 | 50.60 | 0.23 (0.34%) |
17.56% | 8.04% | 3.51B | 65.33 | 2.57% | 63.99 | 4.72% |
B Buy |
| 17 | NTRA | Natera, Inc. | 37.36 | 36.13 | 38.28 | 36.13 | 40.92 | 11.08 | 0.98 (2.69%) |
167.62% | 118.34% | 2.90B | 37.19 | 0.45% | 27.69 | 34.92% |
B Buy |
| 18 | NSTG | NanoString Technologies, Inc. | 26.14 | 26.19 | 26.30 | 25.44 | 34.78 | 13.26 | -0.07 (-0.27%) |
76.26% | 49.14% | 934.19M | 23.38 | 11.79% | 25.67 | 1.82% |
B Buy |
| 19 | HSKA | Heska Corporation | 94.53 | 93.60 | 94.80 | 93.04 | 102.09 | 62.47 | 0.99 (1.06%) |
9.79% | -3.68% | 739.98M | 83.66 | 13.00% | 78.99 | 19.67% |
B Buy |
| 20 | OXFD | Oxford Immunotec Global PLC - Ordinary Shares | 17.28 | 17.20 | 17.30 | 17.08 | 18.60 | 11.88 | 0.00 (0.00%) |
35.21% | 15.82% | 457.00M | 16.04 | 7.72% | 15.24 | 13.39% |
B Buy |
| 21 | BASI | Bioanalytical Systems, Inc. | 4.47 | 4.48 | 4.58 | 4.33 | 5.43 | 1.18 | -0.08 (-1.76%) |
251.97% | 224.34% | 46.92M | 4.38 | 1.97% | 2.76 | 61.82% |
B Buy |
| 22 | EXAS | Exact Sciences Corporation | 85.26 | 83.84 | 85.56 | 83.30 | 123.99 | 53.06 | 1.07 (1.27%) |
35.12% | 22.62% | 11.07B | 86.77 | -1.74% | 100.26 | -14.96% |
C Neutral |
| 23 | IRTC | iRhythm Technologies, Inc. | 66.46 | 68.09 | 68.09 | 65.99 | 98.13 | 56.24 | -1.65 (-2.42%) |
-4.35% | -8.78% | 1.65B | 68.82 | -3.43% | 75.20 | -11.62% |
C Neutral |
| 24 | BEAT | BioTelemetry, Inc. | 47.27 | 47.04 | 47.54 | 46.28 | 80.92 | 37.07 | 0.26 (0.55%) |
-20.85% | -27.89% | 1.60B | 42.37 | 11.58% | 48.87 | -3.28% |
C Neutral |
| 25 | PACB | Pacific Biosciences of California, Inc. | 5.06 | 5.07 | 5.08 | 5.01 | 7.60 | 4.37 | 0.02 (0.40%) |
-31.62% | -32.71% | 774.00M | 5.01 | 0.96% | 6.10 | -17.11% |
C Neutral |
| 26 | QTRX | Quanterix Corporation | 25.16 | 24.81 | 25.37 | 24.64 | 36.15 | 17.08 | 0.13 (0.52%) |
37.41% | 26.18% | 704.86M | 22.42 | 12.21% | 25.47 | -1.22% |
C Neutral |
| 27 | SRDX | Surmodics, Inc. | 40.87 | 41.10 | 41.47 | 40.53 | 61.08 | 38.06 | -0.11 (-0.27%) |
-13.52% | -29.19% | 553.75M | 42.34 | -3.47% | 43.63 | -6.33% |
C Neutral |
| 28 | SMLR | Semler Scientific Inc. | 44.75 | 43.50 | 44.75 | 43.50 | 54.50 | 28.53 | 0.65 (1.47%) |
30.09% | 37.69% | 292.26M | 43.31 | 3.33% | 43.98 | 1.74% |
C Neutral |
| 29 | FLGT | Fulgent Genetics, Inc. | 11.83 | 11.33 | 12.02 | 11.33 | 16.50 | 3.09 | 0.41 (3.59%) |
273.19% | 257.68% | 221.34M | 11.38 | 3.99% | 8.36 | 41.49% |
C Neutral |
| 30 | MYGN | Myriad Genetics, Inc. | 25.34 | 24.99 | 25.56 | 24.70 | 48.40 | 20.10 | 0.32 (1.28%) |
-12.83% | -18.72% | 1.89B | 27.90 | -9.18% | 28.90 | -12.31% |
D Sell |
| 31 | NVTA | Invitae Corporation | 17.60 | 17.49 | 17.76 | 16.75 | 28.75 | 9.04 | 0.51 (2.98%) |
59.13% | 42.08% | 1.70B | 18.01 | -2.28% | 21.34 | -17.54% |
D Sell |
| 32 | CDNA | CareDx, Inc. | 21.03 | 21.38 | 21.42 | 20.59 | 41.27 | 18.75 | -0.26 (-1.22%) |
-16.35% | -20.20% | 892.43M | 23.20 | -9.37% | 28.75 | -26.86% |
D Sell |
| 33 | AXDX | Accelerate Diagnostics, Inc. | 15.84 | 15.68 | 16.15 | 15.47 | 24.00 | 10.23 | 0.14 (0.89%) |
37.74% | 11.03% | 865.58M | 16.48 | -3.88% | 18.85 | -15.95% |
D Sell |
| 34 | LNTH | Lantheus Holdings, Inc. | 20.12 | 20.16 | 20.43 | 20.08 | 29.80 | 13.82 | -0.12 (-0.59%) |
28.56% | 19.68% | 789.67M | 20.21 | -0.45% | 23.66 | -14.96% |
D Sell |
| 35 | CO | Global Cord Blood Corporation | 4.37 | 4.40 | 4.46 | 4.36 | 7.73 | 4.14 | -0.03 (-0.68%) |
-32.25% | -26.63% | 531.18M | 4.81 | -9.15% | 5.79 | -24.47% |
D Sell |
| 36 | VIVO | Meridian Bioscience Inc. | 9.22 | 9.38 | 9.40 | 9.13 | 18.80 | 7.63 | -0.14 (-1.50%) |
-46.48% | -50.08% | 394.08M | 9.28 | -0.65% | 11.46 | -19.57% |
D Sell |
| 37 | SENS | Senseonics Holdings, Inc. | 0.99 | 1.00 | 1.01 | 0.97 | 3.37 | 0.80 | 0.02 (2.06%) |
-61.78% | -66.72% | 201.42M | 1.00 | -0.72% | 1.63 | -39.44% |
D Sell |
| 38 | FLDM | Fluidigm Corporation | 2.92 | 2.71 | 2.93 | 2.66 | 14.90 | 2.12 | 0.17 (6.18%) |
-66.13% | -62.76% | 203.13M | 3.62 | -19.40% | 8.93 | -67.31% |
D Sell |
| 39 | LOGC | LogicBio Therapeutics, Inc. | 8.22 | 7.72 | 8.38 | 7.72 | 20.07 | 6.34 | 0.55 (7.17%) |
-20.96% | -45.20% | 188.44M | 9.49 | -13.38% | 11.11 | -26.00% |
D Sell |
| 40 | VNRX | VolitionRX Limited | 4.56 | 4.58 | 4.64 | 4.41 | 6.84 | 1.67 | 0.23 (5.31%) |
151.93% | 116.32% | 187.38M | 5.35 | -14.79% | 3.97 | 14.75% |
D Sell |
| 41 | ENZ | Enzo Biochem, Inc. ($0.01 Par Value) | 2.69 | 2.53 | 2.70 | 2.53 | 4.46 | 2.32 | 0.07 (2.67%) |
-3.24% | -18.11% | 127.93M | 3.10 | -13.32% | 3.35 | -19.66% |
D Sell |
| 42 | CELC | Celcuity Inc. | 10.81 | 10.89 | 10.91 | 10.66 | 25.61 | 9.50 | 0.06 (0.56%) |
-54.94% | -57.15% | 110.82M | 14.07 | -23.15% | 19.16 | -43.57% |
D Sell |
| 43 | HBIO | Harvard Bioscience, Inc. | 2.88 | 2.81 | 2.94 | 2.81 | 4.66 | 1.51 | 0.03 (1.05%) |
-9.43% | -17.00% | 109.63M | 2.86 | 0.54% | 2.89 | -0.36% |
D Sell |
| 44 | OCX | OncoCyte Corporation | 1.93 | 1.82 | 1.93 | 1.80 | 6.92 | 1.16 | 0.14 (7.82%) |
39.86% | 24.19% | 100.31M | 1.72 | 11.99% | 2.79 | -30.72% |
D Sell |
| 45 | CEMI | Chembio Diagnostics, Inc. | 4.25 | 4.08 | 4.31 | 3.95 | 7.90 | 3.80 | 0.12 (2.91%) |
-24.91% | -30.86% | 74.66M | 4.97 | -14.47% | 5.97 | -28.87% |
D Sell |
| 46 | VRML | Vermillion, Inc. | 0.75 | 0.75 | 0.77 | 0.70 | 1.57 | 0.27 | -0.01 (-1.32%) |
150.00% | 50.00% | 72.93M | 0.61 | 23.89% | 0.86 | -12.47% |
D Sell |
| 47 | ONVO | Organovo Holdings, Inc. | 0.48 | 0.47 | 0.48 | 0.46 | 1.18 | 0.22 | 0.00 (0.00%) |
-50.00% | -53.40% | 62.61M | 0.37 | 31.45% | 0.58 | -16.94% |
D Sell |
| 48 | PMD | Psychemedics Corporation | 9.12 | 8.94 | 9.12 | 8.92 | 19.64 | 7.12 | 0.23 (2.59%) |
-38.40% | -43.01% | 50.32M | 9.18 | -0.67% | 10.09 | -9.62% |
D Sell |
| 49 | HTGM | HTG Molecular Diagnostics, Inc. | 0.66 | 0.64 | 0.68 | 0.61 | 3.39 | 0.56 | 0.03 (4.76%) |
-74.02% | -80.36% | 38.31M | 0.77 | -14.18% | 1.58 | -58.25% |
D Sell |
| 50 | CGIX | Cancer Genetics, Inc. | 6.99 | 6.78 | 7.09 | 6.55 | 20.70 | 2.00 | 0.16 (2.34%) |
-2.92% | 17.83% | 14.68M | 4.30 | 62.66% | 5.19 | 34.56% |
D Sell |
| 51 | TROV | TrovaGene, Inc. | 1.30 | 1.34 | 1.35 | 1.27 | 9.65 | 0.88 | -0.04 (-2.99%) |
-58.73% | -68.84% | 10.06M | 1.46 | -11.21% | 2.45 | -46.85% |
D Sell |
| 52 | GENE | Genetic Technologies Ltd representing 150 ordinary shares | 1.88 | 1.81 | 1.94 | 1.81 | 6.32 | 1.56 | 0.08 (4.44%) |
-14.55% | -52.76% | 8.29M | 1.94 | -3.02% | 2.57 | -26.83% |
D Sell |
| 53 | BIOC | Biocept, Inc. | 0.28 | 0.28 | 0.30 | 0.27 | 3.72 | 0.24 | 0.01 (3.70%) |
-67.44% | -70.96% | 6.45M | 0.67 | -58.49% | 0.94 | -70.15% |
D Sell |
| 54 | OPGN | OpGen, Inc. | 1.14 | 1.14 | 1.17 | 1.14 | 40.60 | 0.92 | -0.03 (-2.56%) |
-95.62% | -94.16% | 6.36M | 3.11 | -63.37% | 8.63 | -86.78% |
D Sell |
| NR | NRCIB | National Research Corporation | 53.01 | 51.95 | 53.37 | 50.38 | 58.16 | 40.27 | 4.97 (10.35%) |
-5.44% | 32.56% | 1.30B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
All price changes on this page include dividends and splits.